By Research Area

Hot products

Myocardial Infarction & HF Research

Creative Biolabs offers antibodies for cardiac injury and remodeling studies where researchers need to evaluate ischemic damage, inflammatory repair, fibrosis, and heart failure-associated stress pathways. Myocardial infarction and heart failure research antibodies can be explored through cardiovascular disease research categories with target groups relevant to myocardial infarction antibodies, heart failure biomarker antibodies, cardiac fibrosis antibodies, and cardiomyocyte apoptosis antibodies.

Antibodies for Ischemic Injury and Cardiomyocyte Stress

Myocardial infarction research often begins with the response of cardiomyocytes to ischemic stress, mitochondrial dysfunction, oxidative injury, and cell death signaling. Antibody panels may include structural cardiac markers, stress response markers, and apoptosis-associated targets so that researchers can distinguish tissue injury from downstream remodeling.

Cardiomyocyte identity and structural context: MYH6, MYH7, ACTN2, TNNT2, and related sarcomeric targets.
Stress and hypoxia response: HIF1A, heat shock proteins, oxidative stress markers, and mitochondrial stress-associated proteins.
Cell death signaling: cleaved CASP3, BAX, BCL2-family markers, and TUNEL-adjacent validation strategies when appropriate.

Inflammation After Myocardial Infarction

Post-infarction inflammation is dynamic. Early immune-cell recruitment, cytokine signaling, macrophage transition, and resolution-associated changes can all influence how the injured myocardium moves toward repair or pathological remodeling. Myocardial infarction antibodies used in this context are often selected as time-course tools rather than single end-point readouts.

Research focus	Representative antibody targets	Common research use
Early inflammatory response	MPO, CD11b, Ly6G-related markers, IL-6, TNF-alpha	Immune-cell recruitment and acute inflammatory signaling
Macrophage and repair context	CD68, CD163, CCR2, ARG1, iNOS	Macrophage infiltration, phenotype, and repair-phase interpretation
Cytokine and chemokine signaling	CCL2, IL-1 beta, NF-kB markers	Mechanism studies in tissue or cell models

Cardiac Fibrosis and Ventricular Remodeling Markers

Cardiac fibrosis antibodies are central to heart failure research because extracellular matrix deposition and fibroblast activation are strongly connected to ventricular remodeling. Targets such as COL1A1, COL3A1, ACTA2/alpha-SMA, TGFB1, MMP2, MMP9, TIMP1, periostin, galectin-3, and ST2/IL1RL1 may be used to study the remodeling environment after cardiac injury.

Creative Biolabs organizes these targets around fibrosis, extracellular matrix turnover, myofibroblast activation, and stress-associated signaling, helping researchers compare antibody options by pathway and assay, rather than searching for isolated targets without application context.

Heart Failure Biomarkers and Signaling Pathways

Heart failure biomarker antibodies should be presented as research tools, not diagnostic-use products. ST2 heart failure antibody searches, galectin-3, GDF15, natriuretic peptide-related research markers, inflammatory mediators, hypertrophy markers, and calcium-handling proteins can help researchers evaluate myocardial stress, remodeling, and pathway activity in experimental systems.

Research focus	Representative antibody targets	Common research use
Fibrosis and remodeling	ST2/IL1RL1, LGALS3, TGFB1, COL1A1, COL3A1	Remodeling and matrix-deposition research
Cardiomyocyte stress	HIF1A, HSPs, NPPA/NPPB research context	Stress response and hypertrophy pathway studies
Cell death and repair	CASP3, BAX, BCL2, macrophage markers	Apoptosis, immune response, and repair-phase studies

Browse MI and HF Research Antibodies by Target

Researchers can browse targets by cardiomyocyte injury, post-infarction inflammation, cardiac fibrosis, ventricular remodeling, apoptosis, and heart failure biomarker research. Hot Products may include ST2/IL1RL1, galectin-3, TGFB1, COL1A1, MMP9, CD68, CASP3, and oxidative stress markers, while Target Search provides direct access to named proteins and aliases.

For adjacent cardiovascular applications, compare antibody target groups across Atherosclerosis Research, Hypertension & Vascular Remodeling Research, and Thrombosis & Hemostasis Research
For assay-format planning, see Cardiovascular Research Assay Routing.
If you cannot find a suitable product, please contact our experts for personalized guidance.

FAQ

Which antibody targets are useful for myocardial infarction injury studies?

Researchers often combine cardiomyocyte structural markers with hypoxia, oxidative stress, and apoptosis markers. The target panel should match the model, the post-injury time point, and whether the study focuses on direct injury, inflammation, or remodeling.

How should cardiac fibrosis antibodies be selected?

Cardiac fibrosis studies often require both matrix markers and fibroblast activation markers. COL1A1, COL3A1, ACTA2/alpha-SMA, TGFB1, MMP2, MMP9, and periostin can help build a panel for extracellular matrix deposition and remodeling.

Can ST2 antibody be used in heart failure research?

ST2/IL1RL1 is commonly studied in heart failure-related research contexts. Antibody selection should consider species reactivity, sample type, and assay validation, and any use should remain within research-use-only boundaries.

What is the difference between MI and HF antibody panels?

Myocardial infarction panels often emphasize acute injury, inflammation, and cell death, while heart failure panels tend to emphasize remodeling, fibrosis, stress signaling, and chronic pathway changes. Some targets overlap, but the biological question changes the panel design.

+ Filters

Mouse Anti-MB (Ureaplasma urealyticum) Recombinant Antibody (2F12E5) (CBMAB-YT839LY)

Compare

Target: MB (Ureaplasma urealyticum)

Host: Mouse

Antibody Isotype: IgG2a

Specificity: Ureaplasma urealyticum

Clone: 2F12E5

Application*: WB, ELISA, IP, IF